Experienced in PIK3CA-Related Overgrowth Spectrum

Dr. Adrienne M. Hammill

Pediatric Hematology Oncology
Cincinatti Children's
Children's Hospital Medical Center
3333 Burnet Ave, 
Cincinnati, OH 
Clinical Trials:Currently Recruiting for 1 Trial

Experienced in PIK3CA-Related Overgrowth Spectrum
Cincinatti Children's
Children's Hospital Medical Center
3333 Burnet Ave, 
Cincinnati, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Adrienne Hammill is a Pediatric Hematologist Oncology provider in Cincinnati, Ohio. Dr. Hammill is rated as an Experienced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. Her top areas of expertise are Arteriovenous Malformation, Marshall-Smith Syndrome, Megalencephaly-Capillary Malformation Syndrome, and Perlman Syndrome.

Her clinical research consists of co-authoring 64 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in OH
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
MDwise
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Health
  • HMO
  • PPO
Medical Mutual
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

CHILDREN'S HOSPITAL MEDICAL CENTER
3333 Burnet Ave, Cincinnati, OH 45229
Call: 513-636-4200

Additional Areas of Focus

Dr. Hammill has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)
Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

Identification of Biomarkers for Patients with Vascular Anomalies
Identification of Biomarkers for Patients with Vascular Anomalies
Enrollment Status: Recruiting
Publish Date: November 06, 2024
EPIK-P2: A Phase II Double-blind Study With an Upfront, 16-week Randomized, Placebo-controlled Period, to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)
EPIK-P2: A Phase II Double-blind Study With an Upfront, 16-week Randomized, Placebo-controlled Period, to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)
Enrollment Status: Active_not_recruiting
Publish Date: August 14, 2025
Intervention Type: Drug
Study Phase: Phase 2
The Brain Vascular Malformations Clinical Research Network: Predictors of Clinical Course, Project 2: Innovative Approaches to Gauge Progression of Sturge-Weber Syndrome
The Brain Vascular Malformations Clinical Research Network: Predictors of Clinical Course, Project 2: Innovative Approaches to Gauge Progression of Sturge-Weber Syndrome
Enrollment Status: Active_not_recruiting
Publish Date: February 18, 2025
Managed Access Program (MAP) Cohort Treatment Plan CBYL719F12001M to Provide Access to Alpelisib (BYL719) for Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
Managed Access Program (MAP) Cohort Treatment Plan CBYL719F12001M to Provide Access to Alpelisib (BYL719) for Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
Enrollment Status: Available
Publish Date: October 28, 2024
Intervention Type: Drug
Open-Label, Intra Subject, Dose Escalation (Part 1) Followed by Randomized, Double Blind, Placebo Controlled (Part 2) Trial of Topical VT30 in Pts With Venous, Lymphatic or Mixed Malformations Associated With PIK3CA or TEK Genetic Mutations
Open-Label, Intra Subject, Dose Escalation (Part 1) Followed by Randomized, Double Blind, Placebo Controlled (Part 2) Trial of Topical VT30 in Pts With Venous, Lymphatic or Mixed Malformations Associated With PIK3CA or TEK Genetic Mutations
Enrollment Status: Terminated
Publish Date: August 04, 2022
Intervention Type: Drug
Study Drug: VT30
Study Phase: Phase 1/Phase 2
Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome
Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome
Enrollment Status: Completed
Publish Date: November 01, 2021
Intervention Type: Drug
Study Drug: Sirolimus
Study Phase: Phase 2/Phase 3
View 5 Less Clinical Trials

64 Total Publications

Standardization of Terminology, Definitions, and Outcome Criteria for Bleeding in Hereditary Hemorrhagic Telangiectasia: International Consensus Report.
Standardization of Terminology, Definitions, and Outcome Criteria for Bleeding in Hereditary Hemorrhagic Telangiectasia: International Consensus Report.
Journal: American journal of hematology
Published: June 09, 2025
View All 64 Publications
Similar Doctors
Advanced in PIK3CA-Related Overgrowth Spectrum
Dr. Kiersten W. Ricci
Pediatric Hematology Oncology
Advanced in PIK3CA-Related Overgrowth Spectrum
Dr. Kiersten W. Ricci
Pediatric Hematology Oncology

Children's Hospital Medical Center

3333 Burnet Ave, 
Cincinnati, OH 
 (0.1 miles away)
513-636-4200
Languages Spoken:
English
See accepted insurances

Kiersten Ricci is a Pediatric Hematologist Oncology provider in Cincinnati, Ohio. Dr. Ricci is rated as an Advanced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. Her top areas of expertise are Congenital Athymia, Perlman Syndrome, Megalencephaly-Capillary Malformation Syndrome, and Marshall-Smith Syndrome.

Experienced in PIK3CA-Related Overgrowth Spectrum
Dr. Lori A. Luchtman
Pediatric Hematology Oncology
Experienced in PIK3CA-Related Overgrowth Spectrum
Dr. Lori A. Luchtman
Pediatric Hematology Oncology

Children's Hospital Medical Center

3333 Burnet Ave, 
Cincinnati, OH 
 (0.1 miles away)
513-636-4200
Languages Spoken:
English
See accepted insurances

Lori Luchtman is a Pediatric Hematologist Oncology provider in Cincinnati, Ohio. Dr. Luchtman is rated as an Experienced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. Her top areas of expertise are Evans Syndrome, Hemoglobin C Disease, Hemoglobinopathy, and Hemoglobin E Disease.

Experienced in PIK3CA-Related Overgrowth Spectrum
Dr. Charles T. Quinn
Pediatric Hematology Oncology
Experienced in PIK3CA-Related Overgrowth Spectrum
Dr. Charles T. Quinn
Pediatric Hematology Oncology
3333 Burnet Ave., Ml 7015, 
Cincinnati, OH 
 (0.1 miles away)
513-636-4266
Languages Spoken:
English
See accepted insurances

Charles Quinn is a Pediatric Hematologist Oncology provider in Cincinnati, Ohio. Dr. Quinn is rated as an Elite provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. His top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Hemolytic Anemia, and Congenital Hemolytic Anemia.

VIEW MORE PIK3CA-RELATED OVERGROWTH SPECTRUM DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hammill's expertise for a condition
ConditionClose
    • Distinguished
    • Arteriovenous Malformation
      Dr. Hammill is
      Distinguished
      . Learn about Arteriovenous Malformation.
      See more Arteriovenous Malformation experts
    • Advanced
    • Aase Syndrome
      Dr. Hammill is
      Advanced
      . Learn about Aase Syndrome.
      See more Aase Syndrome experts
    • Cantu Syndrome
      Dr. Hammill is
      Advanced
      . Learn about Cantu Syndrome.
      See more Cantu Syndrome experts
    • Congenital Athymia
      Dr. Hammill is
      Advanced
      . Learn about Congenital Athymia.
      See more Congenital Athymia experts
    • Hemi 3 Syndrome
      Dr. Hammill is
      Advanced
      . Learn about Hemi 3 Syndrome.
      See more Hemi 3 Syndrome experts
    • Hemoglobin C Disease
      Dr. Hammill is
      Advanced
      . Learn about Hemoglobin C Disease.
      See more Hemoglobin C Disease experts
    • Hemoglobin E Disease
      Dr. Hammill is
      Advanced
      . Learn about Hemoglobin E Disease.
      See more Hemoglobin E Disease experts
    View All 12 Advanced Conditions
    • Experienced
    • Adult Soft Tissue Sarcoma
      Dr. Hammill is
      Experienced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Anemia
      Dr. Hammill is
      Experienced
      . Learn about Anemia.
      See more Anemia experts
    • Bannayan-Riley-Ruvalcaba Syndrome
      Dr. Hammill is
      Experienced
      . Learn about Bannayan-Riley-Ruvalcaba Syndrome.
      See more Bannayan-Riley-Ruvalcaba Syndrome experts
    • Blood Clots
      Dr. Hammill is
      Experienced
      . Learn about Blood Clots.
      See more Blood Clots experts
    • Congenital Hemolytic Anemia
      Dr. Hammill is
      Experienced
      . Learn about Congenital Hemolytic Anemia.
      See more Congenital Hemolytic Anemia experts
    • Embryonal Tumor with Multilayered Rosettes
      Dr. Hammill is
      Experienced
      . Learn about Embryonal Tumor with Multilayered Rosettes.
      See more Embryonal Tumor with Multilayered Rosettes experts
    View All 24 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2025 All Rights Reserved